To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Genzyme's woes following the shutdown of its Allston ...
The FDA issued a warning letter to Sanofi regarding significant manufacturing violations at its Genzyme Corporation Facility in Framingham, Mass. The letter, dated Dec. 16, 2024, and amended Jan. 15, ...
(Refiles to insert dropped word "Cerezyme" in paragraph 15) * No quick answers to Genzyme's manufacturing woes * Competitors work to upgrade plants, reduce risk By Toni Clarke BOSTON, Oct 20 (Reuters) ...
This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. Vials of five drugs produced by Genzyme Corp. of Framingham, Mass., have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results